Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy?

Author(s):
Sande, M.A.E. van de; Creutzberg, C.L. (0000-0002-7008-4321); Water, S. van de; Sharfo, A.W.; Hoogeman, M.S.
Published
2016
Publication type
Article / Letter to editor
IMPTIMRTCervical cancerEndometrial cancerTreatment technique comparison
Date issued
2016-09-30
Language
English
Is part of
Radiotherapy and Oncology (2016), Vol. 120, no. 3, p. 397-403
hdl
1887/113006
doi
10.1016/j.radonc.2016.06.016